Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00655291 · ClinicalTrials.gov registry record · Phase 3
Efficacy of XP20B Following Bunionectomy Surgery
A Phase 3 study of Acute Pain, sponsored by Xanodyne Pharmaceuticals.
- Completed
- Registry status
- Phase 3
- Development phase
- 190
- Enrollment target
- 6
- Study locations
NCT00655291: Completed Phase 3 study of Acute Pain, sponsored by Xanodyne Pharmaceuticals.
NCT00655291 is a Phase 3 study of Acute Pain that has completed, run by Xanodyne Pharmaceuticals. The registered enrollment target is 190 participants, below the 264-participant average among 50 other Acute Pain trials with a reported enrollment target (28% lower). The trial reports 6 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00655291, a Phase 3 study of Acute Pain, has completed, sponsored by Xanodyne Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 190 participants
- Enrollment target
- 6
- Study locations
Study Summary
The purpose of this study is to determine if XP20B is an effective treatment for the relief of pain following bunionectomy surgery.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG XP20B
Study Locations (6)
Texas
- Investigative Site - Austin
- Investigative Site - Houston
- Investigative Site - San Marcos
California
- Investigatve Site - Anaheim
Maryland
- Investigative Site - Owings Mills
Utah
- Investigative Site - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 190 participants |
| Start Date | 2008-04 |
| Est. Completion | 2008-08 |
| Phase | Phase 3 |
What the finished NCT00655291 record still lists
NCT00655291 is an interventional study that assigns participants to a tested intervention. The registered 190 participants enrollment target is mid-sized for trials with a published cap, below the 264-participant average among 50 other Acute Pain trials with a reported enrollment target (28% lower).
The record links to 1 condition, with Acute Pain appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT00655291 lists 6 locations in 4 states (Texas, California, Maryland).
Frequently Asked Questions
What is clinical trial NCT00655291 about?
NCT00655291 is a clinical study titled "Efficacy of XP20B Following Bunionectomy Surgery". The purpose of this study is to determine if XP20B is an effective treatment for the relief of pain following bunionectomy surgery.
What is the current status of trial NCT00655291?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 190 participants. The study started on 2008-04. Estimated completion is 2008-08.
What conditions does trial NCT00655291 study?
This clinical trial studies the following conditions: Acute Pain.
What interventions are being tested in trial NCT00655291?
The interventions under investigation include: Placebo (DRUG), XP20B (DRUG).
Who is sponsoring clinical trial NCT00655291?
This trial is sponsored by Xanodyne Pharmaceuticals, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00655291 being conducted?
This trial has 6 study locations across California, Maryland, Texas, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00655291's enrollment target sits among peer trials
190 17th of 50 higher than 34 of 50 other Acute Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Acute Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Efficacy of Lidocaine Patch in Acute Musculoskeletal Pain in the Emergency Department
COMPLETED · Phase 3
-
Diclofenac Patch for the Treatment of Acute Pain Due to Mild to Moderate Wrist Sprain, Strain or Contusion
COMPLETED · Phase 3
-
Erector Spinae Block Versus Surgeon Infiltration in VATS Procedures
COMPLETED · Phase 3
-
A Study of Cebranopadol for the Treatment of Acute Pain After Bunionectomy
COMPLETED · Phase 3
-
Clinical Trial Comparing Two Protocols Using Intravenous (IV) Hydromorphone
COMPLETED · Phase 3
-
Efficacy and Safety of Oxymorphone Immediate Release in Post-surgical Acute Pain
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03257033 · 190 participants · Phase 3
Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPC
- NCT03642028 · 190 participants · Phase 4
Suvorexant: A Dual Orexin Receptor Antagonist for Treating Sleep Disturbance in Posttraumatic Stress
- NCT04015609 · 190 participants · NA
Psychotherapy Intervention for Latinos With Advanced Cancer
- NCT04284397 · 190 participants · Early Phase 1
Identification of Critical Thermal Environments for Aged Adults
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia